Objective: To determine visceral adipose tissue (VAT) volume (VAT vol ) by dual energy X-ray absorptiometry (DXA) in spinal cord injured (SCI) and able-bodied (AB) participants and to explore the relationships between VAT vol and routine anthropometric measures. Methods: Sixty-three subjects with SCI and 126 healthy male AB controls were stratified as low risk [LR: waist circumference (WC) < 102 cm] and moderate to high risk (MHR: WC 102 cm) for identification of risk for cardiometabolic disease: AB-LR, SCI-LR, AB-MHR, and SCI-MHR. Anthropometrics and standard body composition measurements by DXA with analysis to derive VAT vol were performed.
Introduction
Visceral adipose tissue (VAT) accumulates in the peritoneal cavity in the upper part of the abdomen and surrounds the liver, stomach, pancreas, and the mesentery (1) . Unlike subcutaneous adipose tissue (SAT), VAT is highly vascularized and contains large fat cells that contribute to a hyperlipolytic state and an increased hepatic glucose output (2) . Accumulation of fat mass in the visceral cavity is a primary contributor to the metabolic syndrome, type 2 diabetes mellitus, and heightened risk of cardiovascular disease (3) . Spinal cord injury (SCI) results in extreme physical inactivity with a higher percent of total body fat and the accumulation of excess fat in the visceral cavity (4) (5) (6) (7) . At the time of acute SCI, there is a loss of lean tissue mass (LTM) primarily below the level of lesion (8, 9) , decreased resting energy expenditure, and increased relative and absolute adiposity (10) , a process that continues into the chronic phase of injury (11) . As a result of these adverse body composition changes, persons with SCI appear to be at greater risk for metabolic disorders and, eventually, atherosclerotic vascular disease (12) .
VAT has been traditionally estimated through the use of indirect surrogate anthropometric measures, such as waist circumference (WC) and waist-to-hip ratio in the able-bodied (AB) population (13, 14) . The measurement of abdominal adiposity in the lumbar region (L1-L4) by dual energy X-ray absorptiometry (DXA) is similar to other more commonly used anthropometric measures and thus limited in its predictive value of visceral adiposity (15, 16) . Body mass index (BMI) in those with SCI spuriously underestimates total body fat due to loss of LTM in the lower extremity and would be anticipated to underestimate visceral adiposity as well. In persons with SCI, recent reports have demonstrated WC as the best indicator of risk of cardiovascular disease (17) . To date, abdominal computed tomography (CT) and magnetic resonance imaging (MRI) have been the only direct measures of VAT (18) (19) (20) ; despite being the current "gold standard" reference techniques to determine VAT, these approaches to measure VAT are expensive and time intensive, and CT imaging is associated with a high level of radiation exposure. A recent FDA-approved software upgrade for DXA imaging has been validated against CT (R 2 5 0.957) to measure visceral fat by determining abdominal fat from the android region and then calculating the differentiated compartments of SAT and VAT mass and volume (21) (22) (23) . This method is fully automated, inexpensive, and readily available.
The objectives of the current investigation were as follows: (1) to compare measures of DXA-estimated VAT, total and regional standard soft tissue values, and commonly used anthropometric measures between the SCI and AB cohorts; (2) to compare the quantity of VAT within and between those with low and moderate to high cardiometabolic risk in the SCI and AB groups; and (3) to calculate the VAT volume cutoff values for increased metabolic risk in the SCI and AB cohorts. We hypothesize that individuals with SCI will have a greater quantity of VAT per unit of BMI or WC than that in agematched AB subjects.
Methods Subjects
The demographics of the subjects are presented (Table 1) . Sixtythree male, non-ambulatory, wheelchair dependent subjects with SCI (33 paraplegia and 30 tetraplegia), and 126 healthy AB controls between 20 and 64 years of age were recruited for participation. This was accomplished for SCI and AB subjects using an existing database, referral from study physicians, word of mouth, and IRB approved advertisements at the James J. Peters Veterans Affairs Medical Center (JJPVAMC), Bronx, NY, the Kessler Institute for Rehabilitation (KIR), West Orange, NJ, and, for AB controls using an existing database, at the University of Minnesota (UM), Minneapolis, MN. Individuals with SCI were included if they had a chronic injury (1 year), regardless of completeness or mechanism of injury, and if they were clinically stable. Subjects were excluded from participation if they had been diagnosed by a physician with a pressure ulcer, diabetes, coronary heart disease, lacked mental capacity to provide informed consent, and/or any other chronic illness. Using the American Spinal Injury Association Impairment Scale (AIS) to classify neurological impairment, 29 SCI subjects were previously diagnosed with a motor-complete injury (AIS A or B), 34 subjects with a motor-incomplete injury (AIS C), and the AB controls were age-matched to the SCI participants. The study was approved by the Institutional Review Boards at the JJPVAMC, KIR, and UM, and informed consent was obtained for all subjects prior to study participation.
Procedures
Studies were performed during a single visit to one of the participating study sites. Subjects performed body composition measurements wearing light clothing with shoes removed prior to testing. Subjects were instructed to be free of all plastic and metal objects (i.e., rings, necklaces, etc.), arrive in the morning between 8:00 and 10:00 am after a 12-h fast, and abstain from alcohol, caffeine, and strenuous exercise for 24 h prior to testing.
Body composition measures
A total body scan was performed in accordance with the manufacturer guidelines using a fan beam DXA (GE Healthcare Lunar iDXA, platform version 13.6, GE Healthcare Lunar, Madison, Wisconsin, USA). Because of the possibility of contractures and spasms in the men with SCI, particular effort was made to position each subject. To maintain consistency of body composition measurements, body weight was recorded as the total body mass from the DXA scan. To analyze the results of total body fat mass (TBF mass ), percent total body fat (TBF%), and leg fat mass (LF mass ) from each total body scan, proprietary software algorithms from the manufacturer were used to segment the body into the upper and lower extremities using the standard regions of interest (ROI). Body segments were then adjusted in the total body scan image in a similar manner for each subject by a single investigator who was located at each institution.
After completing the total body DXA scan, participants remained in the supine position and weight was obtained from the DXA total mass [mass 5 weight (Wt)]; body length [length 5 height (Ht)] was determined from the DXA total body scan by using electronic calipers to measure the length from the top of the skull to the calcaneus. While in the supine position, WC was measured with a flexible measuring tape at the midpoint between the top of the iliac crest and the lower margin of the last palpable rib in the mid axillary line at the end of several consecutive natural breaths (24) , with the waist circumference-height ratio (WC/HtR) then calculated. All measures were taken in duplicate to the neatest 0.5 cm and the mean value reported.
Quantification of VAT
From a DXA total body (TB) image, subcutaneous adipose tissue mass (SAT mass) and visceral adipose tissue mass (VAT mass) were obtained from the abdominal android fat (AF) mass (AF mass ) region by applying the iDXA enCore TM CoreScan software. The AF mass region of interest (ROI) was defined as the area that begins at the top of the iliac crest and has a height that is 20% of the total distance from the top of the iliac crest to the base of the skull. To measure SAT, the X-ray attenuation of the abdominal cavity in the android region is obtained using the width of the SAT layer on the lateral aspects of the abdomen, the anterior-posterior thickness of the abdomen, and geometric assumptions of fat distribution. The mass for VAT was calculated by subtracting the SAT from total AF. Fat mass (grams) for the SAT, VAT, and AF regions were transformed to volumes using a constant correction factor (density of adipose tissue 5 0.94 g cm
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) and reported as SAT vol , VAT vol , and AF vol .
Statistical analysis
Results are expressed as group mean 6 standard deviation (SD) and 95% confidence intervals (95% CI), where applicable. Using the World Health Organization (WHO) cutoff values for low risk (LR: WC <102 cm) and moderate to high risk (MHR: WC 102 cm5action level II) to control for differences in body habitus for the occurrence of obesity-related cardiometabolic complications (24), participants were stratified into four subgroups: AB-LR, SCI-LR, AB-MHR, and SCI-MHR. Separate paired comparisons were completed to determine differences between the groups (AB and SCI) for each of the body composition variables [weight, BMI, WC, WC/HtR, TBF mass , TBF%, LF mass , AF vol , and SAT vol ] with VAT vol adjusted for TBF mass . The subgroups were then compared using a multivariate analysis of covariance (ANCOVA) adjusted for age and motor completeness (SCI only) for all body composition variables, with the addition of TBF mass as a covariate when comparing VAT vol . To further identify specific subgroup differences, a Bonferroni correction was applied to all comparisons. Univariate Pearson product-moment correlation analysis was used to test relationships between VAT vol and body composition variables among the subgroups. To determine the utility of body composition variables to predict VAT vol , tests of linearity confirmed a linear relationship permitting regression analyses to be performed using the total SCI or total AB groups. A receiver operating characteristic (ROC) curve was performed to determine the obesity cutoff value for DXA derived VAT vol by using the area under the curve (AUC) measurement. Statistical analyses were completed using IBM SPSS Statistics version 22, IBM, Armonk, NY and graphs were generated by Prism (GraphPad Software, version 5.04 for Windows, San Diego, CA). An a priori level of significance was set at P 0.05.
Results
The characteristics of study participants are presented (Table 1 ). In the SCI subgroups stratified by cardiometabolic risk, there were a comparable number of individuals with paraplegia and tetraplegia and the duration of injury between the SCI groups was not statistically different. However, there was a significantly greater number of motor incomplete subjects in the SCI-LR subgroup compared to the SCI-MHR subgroup (P < 0.05); the SCI-MHR subgroup was significantly older than subjects in the AB-LR and AB-MHR subgroups (P < 0.01), and the AB-MHR subgroup was significantly taller than the AB-LR subgroup (P < 0.05).
Body composition group comparisons
Paired analysis of the SCI and AB groups revealed that weight, BMI, TBF%, LF mass , and VAT vol (P < 0.01) were significantly higher in the total SCI group, with a significantly higher SAT vol observed in the total AB group ( Table 2) . A significant group main effect was found for all measures of adiposity when the AB and SCI groups were stratified by cardiometabolic risk (P < 0.001, Table 2 ). By study design, WC, WC/HtR, TBF mass , and AF vol were all significantly higher in the 2 MHR subgroups for all comparisons (P < 0.01). Posthoc analysis revealed that weight and BMI were significantly higher in the AB-MHR subgroup than in the SCI-MHR subgroup (P < 0.01), and that TBF (%) was significantly higher in the SCI-MHR subgroup compared to the AB-MHR subgroup. In the SCI-MHR group, VAT vol was significantly higher when compared to the AB-MHR (P < 0.05), SCI-LR (P < 0.01), and AB-LR (P < 0.001) subgroups (Table 2) . Contrary to the finding of significantly higher VAT vol in the SCI-MHR subgroup when compared to that in the AB-MHR subgroup, SAT vol values were significantly higher in the AB-MHR subgroup than in the SCI-MHR subgroup (P < 0.01, Table 2 ). The combined findings from these analyses suggest that for a comparable WC, there is a marked difference in the compartmentalization of fat mass in the obese AB subgroup compared to the obese SCI subgroup.
Association between body composition variables and VAT vol
The univariate relationships between VAT vol and body composition variables are presented (Table 3 ). In the AB-LR, SCI-LR, and AB-MHR subgroups, a moderate to strong correlation was detected between VAT vol and all body composition variables (P < 0.05). In the SCI-MHR subgroup, VAT vol was most significantly correlated with TBF mass (R 2 5 0.71, P < 0.001). In the SCI-MHR subgroup, VAT vol was not significantly correlated with TBF% (R 2 5 0.08, P 5 NS) but there appeared to be an inverse trend to SAT vol (R 2 5 20.12, P 5 0.08) ( Table 3 ). For the purposes of determining the ability of TBF%, BMI, and WC to predict VAT vol , the LR and MHR subgroups were combined. TBF% was a significant predictor of VAT vol in the SCI (R 2 5 0.47, P < 0.0001) and AB (R 2 5 0.58, P < 0.0001) groups (Figure 1 ), a relationship that was similar between the two groups (slope difference 5 NS). BMI and WC were also significant predictors of VAT vol in the SCI (R 2 5 0.62, P < 0.001 and R 2 5 0.69, P < 0.001, respectively), and AB (R 2 5 0.62, P < 0.001 and R 2 5 0.71, P < 0.001, respectively) groups
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( Figure 2A and B) . Additional analysis of the regression coefficients revealed significantly steeper slopes in the SCI compared to the AB group for BMI and WC as follows: for every unit increase in BMI, there was a 36 cm 3 (20%) greater increase in VAT vol (slope difference 5 P < 0.05, Figure 2A ) and for a 1 cm increase in WC, there was a 19 cm 3 (27%) greater increase in VAT vol (P < 0.01, Figure 2B ).
Calculation of the VAT vol at the conventional waist circumference value for obesity
Using the conventional WC measure of 102 cm, the VAT vol was identified as 1661 cm 3 (AUC 5 0.909, SE 5 0.035, 95% CI: 0.841-0.977, P < 0.001) in the SCI group and 1642 cm 3 (AUC 5 0.918, SE 5 0.024, 95% CI: 0.872-0.964, P < 0.001) in the AB group, with sensitivities of 85 and 79% and specificities of 80 and 92%, respectively. Four subjects (13%) in the SCI-MHR subgroup had VAT volumes greater than the cutoff value identified at 102 cm, and three subjects (6.5%) in the AB-MHR group had VAT volumes less than this cutoff value. Using the regression equations created herein for the SCI and AB groups (see Figure 2A and B), the equivalent WC was 96 and 105 cm, respectively, for the VAT volume cutoffs presented.
Discussion
This study confirms previous findings that persons with SCI have significantly more visceral adiposity compared to an appropriately matched AB cohort (25) (26) (27) (28) . However, our report is the first to identify differing patterns of compartmentalization of adiposity in the SCI and AB cohorts employed using this novel and sensitive DXAderived method to determine VAT vol (7, 29) . While the relationship between TBF% and VAT vol was essentially the same between those with SCI and AB, a disproportional increase in visceral adiposity was demonstrated for any given WC or BMI in persons with SCI than that observed in AB controls. At a BMI of 30 kg/m 2 , persons with SCI had 43% more VAT than that present in AB controls (see Figure 2A) . Thus, by either surrogate comparator of obesity (e.g., WC or BMI), persons with SCI have a disparate increase in VAT compared to AB controls, marked differences that justify the measurement of VAT volume in the SCI population. The above being appreciated, it is also of importance to emphasize that the relationship between TBF% and VAT vol was observed to be quite similar in the AB and SCI groups.
In a study by Edwards et al. (26) , VAT was quantified by CT scan (L4-L5 vertebral level) in 15 young men and women with chronic SCI and compared to 15 age-, gender-, and WC-matched AB controls. At the same WC, the authors found that persons with SCI had a 58% greater mean VAT volume and a 48% greater mean ratio of VAT vol to SAT vol than that of AB controls. Edwards et al. also found VAT was significantly correlated to WC, and that SAT was not significantly different between the SCI and AB groups, despite similar WC values. Our findings demonstrated a significantly higher VAT vol in the SCI-MHR subgroup than in the AB-MHR subgroup. However, unique to our study, a higher SAT vol was found in the total AB group and the AB-MHR subgroup compared to the respective SCI groups. One possible reason for these apparently conflicting findings may have been the relatively smaller region by single slice CT (L4-L5) used by Edwards et al. in identifying VAT crosssectional area. Measurement of total VAT vol in the abdominal compartment can only be quantified by multi-slice CT and is less feasible due to its limited availability when compared to the DXA methodology that has been applied in our report.
In 1963, Randle et al. (30) hypothesized that the elevation of free fatty acids could interfere with glucose uptake in skeletal muscle and antagonize the action of insulin on the liver. Chronically exposing the liver to excess free fatty acids was found to be directly related to excessive intra-abdominal fat deposition (2) . Since that time, high visceral adiposity has been established as a phenotype which is strongly correlated to metabolic and cardiovascular disease (13, 31) . There is a growing body of evidence suggesting that increases in physical activity without changes in body weight can be effective in reducing visceral adiposity (32, 33) . Thus, it would seem reasonable to postulate that the contrary-that is, a sedentary lifestyle, independent of weight gain, may predispose individuals susceptible to relatively greater visceral fat deposition. In addition to the physiological and socioeconomic barriers to effective exercise programs (34) , persons with SCI spend on average 9.2 h per day sitting in a wheelchair (35) , making a sedentary lifestyle for most of these individuals inevitable. In this study, the higher SAT values in the AB-LR and AB-MHR cohorts may reflect a cardioprotective mechanism, whereby excess free fatty acids are stored in the subcutaneous compartment instead of the visceral abdominal area to (36) . The SCI participants in our study were not diabetic, but occult abnormalities in carbohydrate metabolism may certainly have been present because of the prevalence of insulin resistance and impaired glucose tolerance that has been reported to be substantially higher in the SCI population than that in the general population (12, 37) .
The ROC curve was used to identify the optimum VAT vol cutoff point (i.e., with maximum sensitivity and specificity). By interpretation of the AUC in the ROC curve, the VAT vol measurement can be used to identify increased metabolic risk 91 and 92% of the time in the SCI and AB groups, respectively. Our findings of a lower WC cutoff value in the SCI group (96 vs. 102 cm) are in accordance with previous studies (17) . In a study by Ravensbergen and colleagues, using a Framingham 30-year risk score of 10% as a positive outcome, the authors found the optimal WC cutoff value for their male SCI subjects to be 94 cm, instead of the conventional cutoff value of 102 cm for AB males (17) .
There are limitations to our study design. Similar body composition studies that have been performed in the AB populations with obesity generally have a larger number of participants than our work reported herein in those with SCI, but it should be appreciated that the SCI population available for such studies is invariably smaller, which limits the generalizability of these results. The SCI subjects were not stratified by level or completeness of lesion, which limits applicability of our finding to specific neurological impairment and functional ability. Future validation studies are needed to compare the described DXA-derived method to more conventional CT imaging methods and markers of cardiometabolic risk in persons with SCI of varying ages and genders. Finally, although none of our participants reported regular moderate to vigorous exercise participation, details of their physical activity may have assisted in the analysis of our VAT vol findings.
Conclusion
Compared to the AB cohort, persons with SCI had a disproportionate increase in visceral adiposity for any given unit in WC or BMI. The use of DXA-derived VAT vol appears to be a more accurate indicator of visceral adiposity in persons with SCI than that of other more commonly used methods in clinical practice. This report confirms and extends previous findings that a higher percent of persons with SCI may be speculated to be at increased cardiometabolic risk because of greater visceral adiposity. We propose additional studies to confirm our initial findings of lower cutoff values for adiposity for WC and BMI that have been generated from our VAT vol findings. The alternative to adjusting surrogate measures of visceral adiposity is to directly obtain measurement of VAT vol by DXA, which is currently a readily available commercial method. By directly determining VAT vol , or by applying lower cutoff values from the surrogate markers of obesity, these approaches should provide clinicians with an improved ability to identify and manage obesityrelated cardiometabolic risk by more appropriately counseling persons with SCI who have been identified as being at higher risk of cardiovascular disease to maintain healthier lifestyles.O
